back to Meetings page
  • IMMPACT-II
  • April 11-12, 2003
  • Willard InterContinental Hotel
  • Washington, DC

  • Co-chairs:
  • Dennis C. Turk, PhD (University of Washington)
  • Robert H. Dworkin, PhD (University of Rochester)
  • Academia Participants
  • Nicholas Bellamy, MD (University of Queensland)
  • Daniel Carr, MD (Tufts University)
  • Charles Cleeland, PhD (MD Anderson Cancer Center)
  • John T. Farrar, MD (University of Pennsylvania)
  • Alejandro Jadad, MD (University of Toronto)
  • Nathaniel P. Katz, MD (Harvard University)
  • Michael McDermott, PhD (University of Rochester)
  • Patrick McGrath, PhD (Dalhousie University)
  • James P. Robinson, MD, PhD (University of Washington)
  • Wendy Stein, MD (University of California, San Diego)
  • Government Participants
  • Raymond Dionne, DDS, PhD (US National Institute of Health)
  • Cynthia G. McCormick, MD (US National Institute of Health)
  • Bob A. Rappaport, MD (US Food and Drug Administration)
  • Lee Simon, MD (US Food and Drug Administration)
  • Jane Tollett, RN, PhD (US Department of Veterans Affairs)
  • James Witter, MD, PhD (US Food and Drug Administration)
  • Industry Participants
  • Robert R. Allen, MD (AstraZeneca)
  • Nancy Brandenburg, PhD (Pfizer)
  • Bradley S. Galer, MD (Endo Pharmaceuticals)
  • David J. Hewitt, MD (Ortho-McNeil Pharmaceutical)
  • Lynn D. Kramer, MD (Purdue Pharma)
  • Donald C. Manning, MD, PhD (Novartis Pharmaceuticals Corporation)
  • Steve Quessy, PhD (GlaxoSmithKline)
  • Michael A. Royal, MD, JD (Elan Pharmaceuticals)
  • Joseph W. Stauffer, DO (Abbott Laboratories)